Summary: New genetic research indicates that depression can raise the risk of menstrual pain (dysmenorrhea), with sleep problems likely acting as an important mediator. Using Mendelian randomization and large-scale genomic data, researchers found evidence that depression is more likely to cause period pain than to be caused by it. The results underline the need to consider mental health and sleep quality when treating severe menstrual pain.
Key Facts:
- Genetic evidence suggests depression contributes to menstrual pain (dysmenorrhea) rather than vice versa.
- Sleep disturbances, commonly linked to depression, appear to worsen menstrual pain and may mediate this relationship.
- The findings support routine mental health and sleep screening for people with severe period pain and encourage integrated care approaches.
Source: Xi’an Jiaotong-Liverpool University
Background
Depression affects women at approximately twice the rate of men and often presents with more pronounced physical symptoms during reproductive years. While connections between mental health and reproductive health have been observed, the causal relationships have not been fully clarified. A collaborative team from China and the UK investigated whether depression can causally influence dysmenorrhea using genetic methods designed to reduce confounding and reverse causation.
Shuhe Liu, the study’s lead author and a PhD candidate at Xi’an Jiaotong-Liverpool University (XJTLU), explains that the team applied Mendelian randomization to genetic datasets to probe causality. By leveraging genetic variants associated with depression and dysmenorrhea, the researchers aimed to determine whether genetic liability to depression increases the risk of menstrual pain and to identify biological pathways that might link the two conditions.
The analysis drew on GWAS (genome-wide association study) data from roughly 600,000 individuals of European ancestry and about 8,000 individuals of East Asian ancestry. The concordant results across these populations supported a directional effect from depression to dysmenorrhea. Importantly, the reverse effect—dysmenorrhea causing depression—was not supported by the genetic analyses.
Beyond establishing likely causality, the team evaluated potential mediators. Sleep disturbances, which commonly co-occur with depression, emerged as a significant factor that could exacerbate menstrual pain. Addressing sleep problems may therefore be an important component of treating both depression and severe dysmenorrhea, although further research is needed to map the detailed mechanisms.
Clinical implications
These findings support a more integrated, holistic approach to care. Screening for mental health conditions and sleep difficulties in patients who present with significant menstrual pain could enable more personalized care plans and targeted interventions. The authors also emphasize that considering the neurological and systemic links between the brain and reproductive system may reduce stigma and improve outcomes for people affected by both conditions.
Liu is supervised by Professor John Moraros and Dr Zhen Wei of XJTLU, and Dr Dan Carr from the University of Liverpool. The research adds to a growing body of evidence that mental health and reproductive health are closely interconnected and may share underlying genetic and molecular pathways.
About this research
Author: Catherine Diamond
Source: Xi’an Jiaotong-Liverpool University
Contact: Catherine Diamond – Xi’an Jiaotong-Liverpool University
Image: The image is credited to Neuroscience News
Original Research: Open access. “Deciphering the genetic interplay between depression and dysmenorrhea: a Mendelian randomization study” by Shuhe Liu et al. DOI: 10.1093/bib/bbae589
Abstract
Deciphering the genetic interplay between depression and dysmenorrhea: a Mendelian randomization study
Background
This study used an integrated approach combining genomic, transcriptomic, and protein-interaction data to investigate the relationship between depression and dysmenorrhea. The goal was to determine causality and to identify genes and pathways that might mediate the interaction.
Methods
Researchers applied a two-sample, bidirectional, multivariate Mendelian randomization framework to test causal effects between dysmenorrhea and depression. GWAS data identified genetic variants linked to each condition. Colocalization analyses were used to detect shared genetic signals. Expression quantitative trait loci (eQTL) data from public resources helped pinpoint likely target genes in relevant tissues, and protein–protein interaction (PPI) networks were constructed to explore functional relationships among implicated proteins.
Results
The MR analysis indicated a significant causal effect of genetic liability to depression on dysmenorrhea, with an odds ratio of 1.51 (95% CI: 1.19–1.91; P = 7.26 × 10−4). There was no evidence supporting a causal effect of dysmenorrhea on depression (P = .74). Integrative genetic analyses highlighted variants and genes including GRK4, TRAIP, and RNF123 as potentially involved in how depression might influence reproductive function. Colocalization pointed to rs34341246 (RBMS3) as a candidate shared causal variant. The PPI network provided a more detailed view of interactions among implicated proteins.
Conclusions
The study provides genetic evidence that depression can significantly influence dysmenorrhea and identifies candidate genes and molecular pathways underlying this relationship. These findings support integrated clinical and public health strategies that include mental health and sleep assessments for individuals presenting with severe period pain and suggest avenues for targeted prevention and treatment research.